1Y Annualised Return
▲34.57%
3Y Annualised Return
▲216.90%
5Y Annualised Return
▲154.63%
Shukra Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹77,69,218 (+19.53%)
Daily SIP of ₹25,000 would have become ₹77,69,218 in 1 year with a gain of ₹12,69,218 (+19.53%)
Shukra Pharmaceuticals Stock Performance
Today’s Low - High
14.62
14.62
14.62
14.62
52 Week Low - High
5.75
27.15
5.75
27.15
Open
14.62
Prev. Close
14.91
Volume
1,59,735.00
Total Traded Value
23.35 L
Shukra Pharmaceuticals Fundamental
Market Cap (in crs)
640.18
Face Value
1
Turnover (in lacs)
23.35
Key Metrics
Qtr Change %
46.15% Fall from 52W High
-40.5
Dividend yield 1yr %
Above industry Median
0.7
Shukra Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
14.62
Current Price
5Day EMA
14.50
10Day EMA
14.20
12Day EMA
14.10
20Day EMA
14.20
26Day EMA
14.40
50Day EMA
15.60
100Day EMA
16.20
200Day EMA
14.60
5Day SMA
14.50
10Day SMA
13.90
20Day SMA
13.80
30Day SMA
13.60
50Day SMA
15.70
100Day SMA
19.10
150Day SMA
16.10
200Day SMA
13.80
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 159735 Rs | 159735 Rs |
Week Rs | 70268 Rs | 70268 Rs |
Month Rs | 144545 Rs | 144545 Rs |
Resistance & Support
14.62
Pivot
Resistance
First Resistance
14.62
Second Resistance
14.62
Third Resistance
14.62
Support
First Support
14.62
Second support
14.62
Third Support
14.62
Relative Strength Index
52.28
Money Flow Index
76.12
MACD
-0.27
MACD Signal
-0.62
Average True Range
0.42
Average Directional Index
20.62
Rate of Change (21)
4.58
Rate of Change (125)
111.58
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 658.14 | 68.72 | 186 | 110.26 | 17.16% | 44.95% | -4.24% | -8.88% | 83.71% | 0.00% | 7.28 | 42.57 | 0.64 | |
- | 611.27 | 270.25 | 476.9 | 445.70 | 6.35% | 45.08% | 37.10% | 21.75% | 114.34% | 0.00% | 13.31 | 42.57 | 1.04 | |
- | 582.27 | 813.5 | 1375 | 1,281.95 | 1.18% | 27.66% | 0.54% | 57.07% | 145.85% | 1.36% | 18.16 | 42.57 | 3.39 | |
- | 648.90 | 957 | 2777.95 | 1,060.00 | -0.92% | -4.74% | -44.70% | -55.08% | 0.00% | 0.00% | 35.62 | 42.57 | 2.31 | |
- | 581.59 | 250 | 515 | 495.10 | 7.45% | 22.55% | 25.01% | 56.02% | 590.50% | 0.00% | 0.00 | 42.57 | 23.15 | |
- | 687.69 | 210.1 | 374.5 | 312.60 | -1.57% | 1.42% | -1.83% | -3.72% | 93.40% | 0.00% | 39.21 | 42.57 | 2.41 |
Shukra Pharmaceuticals Company background
Founded in: 1993
Managing director: Dakshesh Shah
Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314, the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited with the erstwhile Relish Pharmaceuticals Limited and Reorganization of Share Capital of Relish Pharmaceuticals Limited through the Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 December, 2013.
As of 13 Jun, 2025, SHUKRAPHAR share price is ₹14.6. The stock opened at ₹14.6 and had closed at ₹14.9 the previous day. During today’s trading session, SHUKRAPHAR share price moved between ₹14.62 and ₹14.62, with an average price for the day of ₹14.00. Over the last 52 weeks, the stock has recorded a low of ₹5.75 and a high of ₹27.15. In terms of performance, SHUKRAPHAR share price has increased by 101.1% over the past six months and has increased by 34.57% over the last year.
Shukra Pharmaceuticals FAQs
How to buy Shukra Pharmaceuticals shares?
You can easily buy Shukra Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Shukra Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account